This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
saas: Archive
Should You Buy, Sell or Hold IBM Stock Before Q2 Earnings?
by Supriyo Bose
IBM heads into Q2 earnings with AI and cloud momentum, but premium valuation, margin pressure and weaker estimates argue for caution.
IBMNegative Net Change AMZNNegative Net Change MSFTNegative Net Change
artificial-intelligence cloud-computing computers earnings-preview iot saas software tech-stocks telecom
Can Visa's Stablecoin Platform Accelerate Enterprise Blockchain Use?
by Rajshree Sipani
V's Stablecoin Platform aims to simplify blockchain payments, helping institutions adopt stablecoins while expanding enterprise use cases.
VNegative Net Change MANegative Net Change PYPLNegative Net Change
blockchain business-services fin-tech finance payments saas
Does Microsoft Stock Present an Opportunity via Teams Monetization?
by Vasundhara Sawalka
MSFT reshapes Teams pricing by moving key features into Enterprise while adding new licenses, making renewal cycles key to its monetization strategy.
MSFTNegative Net Change CRMNegative Net Change ZMNegative Net Change
artificial-intelligence saas tech-stocks
Can Visa Deepen Its Remittance Business Through ACE Partnership?
by Rajshree Sipani
V is expanding its cross-border payments business with ACE Money Transfer to simplify digital remittances and strengthen global money movement.
VNegative Net Change MANegative Net Change PYPLNegative Net Change
blockchain business-services fin-tech finance payments saas
Newsmax (NMAX) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
NMAXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
HubSpot vs. IBM: Which AI Software Stock is a Better Buy Now?
by Supriyo Bose
HUBS' faster 2026 growth outlook, lower valuation and expanding AI capabilities give it an edge over IBM.
IBMNegative Net Change HUBSNegative Net Change AMZNNegative Net Change MSFTNegative Net Change
artificial-intelligence cloud-computing communications iot saas software tech-stocks telecom
Should You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ABVXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Bassett Furniture (BSET)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
BSETNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
LATAM (LTM) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
LTMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Salesforce Bets Big on Informatica: Can It Be CRM's Next Growth Leg?
by Anirudha Bhagat
CRM's Informatica integration boosts AI and data ARR, expanding Data 360 and Agentforce capabilities, and opening new cross-selling opportunities.
CRMNegative Net Change MSFTNegative Net Change ORCLPositive Net Change
artificial-intelligence computers internet saas tech-stocks